Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 11 years
- Director since
- 2023
11 years of board service in total across 3 boards, counting each seat separately. Longest: Avalo Therapeutics Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Celldex Therapeutics Inc. June 25, 202698.5%
-
Avalo Therapeutics Inc. June 2, 2026100.0%
-
Avalo Therapeutics Inc. June 17, 202599.9%
-
Celldex Therapeutics Inc. June 5, 202599.6%
-
Avalo Therapeutics Inc. August 13, 202498.6%
-
Celldex Therapeutics Inc. June 13, 202498.8%
-
Avalo Therapeutics Inc. December 20, 202385.9%
-
Celldex Therapeutics Inc. June 15, 202384.4%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 21, 2026 | Avalo Therapeutics Inc. | Grant or award | +100,200 | — | — |
| Mar 28, 2026 | Avalo Therapeutics Inc. | Option exercise | +64,866 | — | — |
| Mar 28, 2026 | Avalo Therapeutics Inc. | Shares withheld for tax | −21,892 | $13.89 | $304,080 |
| Mar 28, 2025 | Avalo Therapeutics Inc. | Option exercise | +64,867 | — | — |
| Mar 28, 2025 | Avalo Therapeutics Inc. | Shares withheld for tax | −17,787 | $8.46 | $150,478 |
| Jun 9, 2023 | Avalo Therapeutics Inc. | Open-market purchase | +4,000 | $3.42 | $13,680 |
Questions about Garry Arthur Neil
What boards is Garry Arthur Neil on?
Garry Arthur Neil sits on the boards of Avalo Therapeutics Inc., Celldex Therapeutics Inc. and Zura Bio Limited.
What company is Garry Arthur Neil the CEO of?
Garry Arthur Neil is CEO and Chairman of the Board of Avalo Therapeutics Inc.
How long has Garry Arthur Neil served on boards?
Our records show at least 11 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.